racemetirosine has been researched along with Behavior Disorders in 2 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Booij, L | 1 |
Van der Does, AJ | 1 |
Riedel, WJ | 1 |
de Haan, L | 1 |
Booij, J | 1 |
Lavalye, J | 1 |
van Amelsvoort, T | 1 |
Linszen, D | 1 |
1 review available for racemetirosine and Behavior Disorders
Article | Year |
---|---|
Monoamine depletion in psychiatric and healthy populations: review.
Topics: alpha-Methyltyrosine; Amino Acids; Biogenic Monoamines; Humans; Mental Disorders; Psychotic Disorder | 2003 |
1 other study available for racemetirosine and Behavior Disorders
Article | Year |
---|---|
Subjective experiences during dopamine depletion.
Topics: Adult; alpha-Methyltyrosine; Benzamides; Corpus Striatum; Dopamine; Enzyme Inhibitors; Humans; Iodin | 2005 |